.png)
£425K
EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.
SP
Spotlight Pathology
Spotlight Pathology develops artificial intelligence tools to speed up blood cancer diagnosis.
United Kingdom—Founded 2020
£550KTotal raised
Spotlight Pathology is a medical technology company developing artificial intelligence tools to assist clinicians in diagnosing blood cancers. Its platform uses proprietary computer vision models to streamline lymph node and bone marrow biopsy workflows.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from Spotlight Pathology's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
MF
Martin Fergie
Co-founder
Investors
- £425K
- £125KLYVA LabsLead
Funding history
£125K
The pre-seed investment from LYVA Labs will accelerate product development and commercialisation.